Pathogenesis and clinical aspects of pain in patients with osteoporosis

被引:40
作者
Mediati, Rocco Domenico [1 ]
Vellucci, Renato [1 ]
Dodaro, Lucia [1 ]
机构
[1] AOU Careggi, Oncol Dept, Palliat Care & Pain Therapy Unit, Florence, Italy
关键词
chronic pain; bone innervation; osteoclasts activity; opioids;
D O I
10.11138/ccmbm/2014.11.3.169
中图分类号
R5 [内科学];
学科分类号
1002 [临床医学]; 100201 [内科学];
摘要
Bone pain is one of the most frequent kinds of chronic pain, mainly in elderly patients. It causes a significant worsening of functional capacity and deterioration in the quality of life in people affected. Mechanisms of pain in osteoporosis are poorly known and often extrapolated by other pathologies or other experimental model. One of principal causes would be a "hyper-remodeling" of bone, that involves osteoclasts activity and pathological modifications of bone innervation. Several studies show that osteoclasts play a significant role in bone pain etiology. Pain in osteoporosis is mainly nociceptive, if it become persistent a sensitization of peripheral and central nervous system can occur, so underlining the transition to a chronic pain syndrome. Central sensitization mechanisms are complex and involve several neuromediators and receptors (Substance P, NMDA, etc.). Most common manifestations of osteoporosis are vertebral compression fractures that cause persistent pain, though to differentiate from pain originating in structures as joint or muscle. First manifestation can be an acute pain due to pathological fracture, those of hip often causes disability. Pain in osteoporosis is an important clinical challenge. Often its complications and consequences on patient quality of life are underestimated with not negligible social implications. A balanced and early multimodal pain therapy including opioids as necessary, even in cases of acute pain, improve the functional capacity of patients and helps to prevent neurological alterations that seems to contribute in significant way in causing irreversible pain chronic syndromes.
引用
收藏
页码:169 / 172
页数:4
相关论文
共 34 条
[1]
[Anonymous], 1986, PAIN S, V3, pS1
[2]
NEUROPEPTIDE Y-IMMUNOREACTIVE, TYROSINE HYDROXYLASE-IMMUNOREACTIVE AND VASOACTIVE INTESTINAL POLYPEPTIDE-IMMUNOREACTIVE NERVES IN BONE AND SURROUNDING TISSUES [J].
BJURHOLM, A ;
KREICBERGS, A ;
TERENIUS, L ;
GOLDSTEIN, M ;
SCHULTZBERG, M .
JOURNAL OF THE AUTONOMIC NERVOUS SYSTEM, 1988, 25 (2-3) :119-125
[3]
Survey of chronic pain in Europe: Prevalence, impact on daily life, and treatment [J].
Breivik, H ;
Collett, B ;
Ventafridda, V ;
Cohen, R ;
Gallacher, D .
EUROPEAN JOURNAL OF PAIN, 2006, 10 (04) :287-333
[4]
DAVIDOVITCH Z, 1988, DENT CLIN N AM, V32, P411
[5]
Dfjmas E, 1987, AMJ MED, V83, P276
[6]
EXPRESSION OF NERVE GROWTH-FACTOR AND NERVE GROWTH-FACTOR RECEPTOR TYROSINE KINASE TRK IN ACTIVATED CD4-POSITIVE T-CELL CLONES [J].
EHRHARD, PB ;
ERB, P ;
GRAUMANN, U ;
OTTEN, U .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1993, 90 (23) :10984-10988
[7]
Haviv B, 2013, IMAJ, V15
[8]
Howe TE, 2011, COCHRANE DATABASE SY
[9]
Effects of teriparatide in postmenopausal women with osteoporosis pre-treated with bisphosphonates: 36-month results from the European Forsteo Observational Study [J].
Jakob, F. ;
Oertel, H. ;
Langdahl, B. ;
Ljunggren, O. ;
Barrett, A. ;
Karras, D. ;
Walsh, J. B. ;
Fahrleitner-Pammer, A. ;
Rajzbaum, G. ;
Barker, C. ;
Lems, W. F. ;
Marin, F. .
EUROPEAN JOURNAL OF ENDOCRINOLOGY, 2012, 166 (01) :87-97
[10]
Jimenez-Andrade JM, 2011, BONE, V46, P523